TABLE 7.
Adverse events | n (%) | Treatment discontinuation n (%) |
---|---|---|
Eczema | 2 (1.2%) | 2 (1.2%) |
Injection site reaction | 1 (0.6%) | 0 (0.0%) |
Pancytopenia | 1 (0.6%) | 1 (0.6%) |
Pruritus | 1 (0.6%) | 0 (0.0%) |
Seborrheic dermatitis | 1 (0.6%) | 0 (0.0%) |
Dermatophyte infection | 1 (0.6%) | 1 (0.6%) |
Upper respiratory tract infection | 1 (0.6%) | 0 (0.0%) |
Worsening PASI score | 5 (3.1%) | ‐ a |
No specified detail.